156 related articles for article (PubMed ID: 2295408)
1. Isoniazid-rifampin-induced hepatitis in hepatitis B carriers.
Wu JC; Lee SD; Yeh PF; Chan CY; Wang YJ; Huang YS; Tsai YT; Lee PY; Ting LP; Lo KJ
Gastroenterology; 1990 Feb; 98(2):502-4. PubMed ID: 2295408
[TBL] [Abstract][Full Text] [Related]
2. Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
Lee BH; Koh WJ; Choi MS; Suh GY; Chung MP; Kim H; Kwon OJ
Chest; 2005 Apr; 127(4):1304-11. PubMed ID: 15821209
[TBL] [Abstract][Full Text] [Related]
3. Ethambutol compared to rifampin in original treatment of pulmonary tuberculosis.
Bobrowitz ID
Lung; 1980; 157(3):117-25. PubMed ID: 7382540
[No Abstract] [Full Text] [Related]
4. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
[TBL] [Abstract][Full Text] [Related]
5. [Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus].
Gendrel D; Nardou M; Mouba JF; Gahouma D; Moussavou A; Boguikouma JB
Arch Fr Pediatr; 1989 Nov; 46(9):645-8. PubMed ID: 2604523
[TBL] [Abstract][Full Text] [Related]
6. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
Grönhagen-Riska C; Hellstrom PE; Fröseth B
Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results of six-month regimens studied in the United States and in Poland.
Snider D; Long M; Zierski M; Rogowski J; Bek E
Chest; 1981 Dec; 80(6):727-9. PubMed ID: 7307596
[No Abstract] [Full Text] [Related]
8. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
Chioléro R
Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
[No Abstract] [Full Text] [Related]
9. Short-course chemotherapy. The Arkansas experience.
Dutt AK; Stead WW
Chest; 1981 Dec; 80(6):724-7. PubMed ID: 7030655
[No Abstract] [Full Text] [Related]
10. Antituberculosis agents.
Goldberger MJ
Med Clin North Am; 1988 May; 72(3):661-8. PubMed ID: 3280912
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis.
Sbarbaro JA
Med Clin North Am; 1980 May; 64(3):417-31. PubMed ID: 6993808
[No Abstract] [Full Text] [Related]
12. Editorial: Isoniazid-associated hepatitis. Reconsideration of the indications for administration of isoniazid.
Israel HL
Gastroenterology; 1975 Aug; 69(2):539-42. PubMed ID: 1150056
[No Abstract] [Full Text] [Related]
13. Fatal hepatitis after treatment with isoniazid and rifampicin in a patient on anticonvulsant therapy.
Bartelink AK; Lenders JW; van Herwaarden CL; van Haelst UJ; van Tongeren JH
Tubercle; 1983 Jun; 64(2):125-8. PubMed ID: 6612792
[TBL] [Abstract][Full Text] [Related]
14. The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.
Girling DJ
Tubercle; 1978 Mar; 59(1):13-32. PubMed ID: 345572
[TBL] [Abstract][Full Text] [Related]
15. [The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
Kuntz HD; Rausch V; Bammel E
Med Welt; 1978 Mar; 29(11):452-4. PubMed ID: 651600
[No Abstract] [Full Text] [Related]
16. [A case of acute hepatitis occurred during treatment with isoniazid and rifampicin (author's transl)].
Kameda K; Kawabata S; Shirai S
Kekkaku; 1980 May; 55(5):247-51. PubMed ID: 7412075
[No Abstract] [Full Text] [Related]
17. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
Kuntz HD; Rausch V
Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291
[No Abstract] [Full Text] [Related]
18. Hepatotoxic reactions in children with severe tuberculosis treated with isoniazid-rifampin.
Tsagaropoulou-Stinga H; Mataki-Emmanouilidou T; Karida-Kavalioti S; Manios S
Pediatr Infect Dis; 1985; 4(3):270-3. PubMed ID: 4000989
[TBL] [Abstract][Full Text] [Related]
19. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
Long MW; Snider DE; Farer LS
Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
[TBL] [Abstract][Full Text] [Related]
20. Isoniazid prophylaxis in hepatitis B carriers.
McGlynn KA; Lustbader ED; Sharrar RG; Murphy EC; London WT
Am Rev Respir Dis; 1986 Oct; 134(4):666-8. PubMed ID: 3767121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
